Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx Rare
July 13, 2026
July 13, 2026
NEW YORK, July 13 -- Warburg Pincus, a private equity firm, issued the following news release:
* * *
Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx Rare
Investment will support continued innovation in rare disease care and help PANTHERx serve more patients while preserving its independent, patient-first model
-
NEW YORK and PITTSBURGH - Warburg Pincus, the pioneer of global growth investing, t . . .
* * *
Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx Rare
Investment will support continued innovation in rare disease care and help PANTHERx serve more patients while preserving its independent, patient-first model
-
NEW YORK and PITTSBURGH - Warburg Pincus, the pioneer of global growth investing, t . . .